Publications

Defining the transcriptional landscape in the classical subtype of pancreatic cancer.

Authors:

Research group: Carroll Group

E-pub date: 1 Dec 2025

Journal name: Nat Genet

75eTiP PerceIVe: Power of liquid biopsy tracking in immunotherapy treated unresectable stage III and stage IV melanoma

Authors: A Javaid, S Cheruvu, PG Corrie, K Edmonds, A Laing, J Larkin, R Lee, R Mair...

Research group: Mair Group

E-pub date: 1 Dec 2025

Journal name: Immuno-Oncology Technology

Supplementary Tables 1-5 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast Cancer

Authors: Y Wu, Z Li, AM Wedn, AN Casey, D Brown, SV Rao, S Omarjee, J Hooda, JS Carr...

Research group: Carroll Group

E-pub date: 27 Nov 2025

Journal name:

Supplementary Figures 1-8 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast Cancer

Authors: Y Wu, Z Li, AM Wedn, AN Casey, D Brown, SV Rao, S Omarjee, J Hooda, JS Carr...

Research group: Carroll Group

E-pub date: 27 Nov 2025

Journal name:

Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma.

Authors: W Cross, I Lyskjær, C Davies, A Bunkum, AM Rocha, T Lesluyes, F Amary, R T...

Research group: Brenton Group

E-pub date: 26 Nov 2025

Journal name: Genome Biol

Commentary on ‘Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments’.

Authors: L Melidis, R de Cesaris Araujo Tavares, X He, S Dhir, D Tannahill, S Balasu...

Research group: Balasubramanian Group

E-pub date: 26 Nov 2025

Journal name: Nucleic Acids Res

Towards a glutathione-cleavable azobenzene linker for antibody-drug conjugates.

Authors: M Kapun, R Patel, M Park, FJ Pérez-Areales, KA Kostadinova, T Wharton, JS ...

Research group: Carroll Group

E-pub date: 25 Nov 2025

Journal name: Chem Commun (Camb)

Data from Imaging Glioblastoma Response to Radiotherapy Using 2H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Authors: F Hesse, AJ Wright, V Somai, F Bulat, F Kreis, KM Brindle

Research group:

E-pub date: 24 Nov 2025

Journal name:

Filters

Research Groups

Core Facilities

Start date

End date

Defining the transcriptional landscape in the classical subtype of pancreatic cancer.

75eTiP PerceIVe: Power of liquid biopsy tracking in immunotherapy treated unresectable stage III and stage IV melanoma

Supplementary Tables 1-5 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer

Supplementary Figures 1-8 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer

Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma.

Commentary on ‘Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments’.

Towards a glutathione-cleavable azobenzene linker for antibody-drug conjugates.

Data from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Defining the transcriptional landscape in the classical subtype of pancreatic cancer.

75eTiP PerceIVe: Power of liquid biopsy tracking in immunotherapy treated unresectable stage III and stage IV melanoma

Supplementary Tables 1-5 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer

Supplementary Figures 1-8 from FOXA1 Reprogramming Dictates Retinoid X Receptor Response in <i>ESR1</i>-Mutant Breast Cancer

Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcoma.

Commentary on ‘Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments’.

Towards a glutathione-cleavable azobenzene linker for antibody-drug conjugates.

Data from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism